Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Structure (London, England : 1993)|February 17, 2015
Structure of EspB from the ESX-1 type VII secretion system and insights into its export mechanismMatthew Solomonson, Dheva Setiaputra, Karl A T Makepeace, et al.
Nature Structural & Molecular Biology|April 28, 2009
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion systemThomas Spreter, Calvin K Yip, Sarah Sanowar, et al.
ACS Chemical Biology|January 6, 2016
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding ProteinsAndrew M King, Dustin T King, Shawn French, et al.
Journal of Chemical Information and Modeling|March 17, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent InhibitorsOlivia Garland, Anh-Tien Ton, Shoeib Moradi, et al.
Nature|January 4, 2023
Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureusJ Andrew N Alexander, Liam J Worrall, Jinhong Hu, et al.
Nature Communications|November 15, 2024
Cryo-EM characterization of the anydromuropeptide permease AmpG central to bacterial fitness and β-lactam antibiotic resistanceHelena E Sverak, Luke N Yaeger, Liam J Worrall, et al.
Signal Transduction and Targeted Therapy|April 27, 2026
Drugging the intrinsically disordered transactivation domain of androgen receptorJon K Obst, Carmen A Banuelos, Kunzhong Jian, et al.
The Journal of Biological Chemistry|October 28, 2011
Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activitiesRoya Zoraghi, Liam Worrall, Raymond H See, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2023
Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2Hong Yu, Liam J Worrall, Thorsten Berger, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 3